Clinical Trial: Inova Heart and Vascular Institute Explores Implant's Potential to Replace Anticoagulants in AFib Stroke Prevention
Clinical Trial Inova Heart and Vascular Institute Explores Implant's Potential to Replace Anticoagulants in AFib Stroke Prevention Physicians at IHVI are investigating alternative solutions for AFib-related stroke prevention that reduce side effects and treatment-related costs, led by IHVI interventional cardiologist Matthew W. Sherwood, MD, MHS, Director of the IHVI LAAC/ WATCHMAN Program. Dr. Sherwood also serves as Co-Director of both the Structural Heart Program and the Cardiac Catheterization Laboratories at IFMC.